Skip to content
OncoSil Medical in the news
ONCOSIL MEDICAL IN THE NEWS
Dr Boreham’s Crucible: OncoSil Medical
OncoSil approval for the treatment of pancreatic cancer
Oncosil Wins CE mark, Breakthrough Designation for Pancreatic Cancer Device
OncoSil Medical Obtains CE Mark and Breakthrough Device Designation for its Pancreatic Tumour Isotope
OncoSil™ Receives CE Marketing Approval
OncoSil Granted FDA Breakthrough Device Designation
The Market Herald
OncoSil Medical’s (ASX:OSL) Device Granted Breakthrough Designation by FDA
OncoSil on Verge of CE Mark Approval
ASX MedTech Junior Displays Promise for Pancreatic Cancer Patients
We are currently in the process of updating our website.
Please contact us using the email address below for any information.